Moderna chief executive officer Stéphane Bancel steps down as chief commercial officer, with president Stephen Hoge assuming ...

During the latest earnings call, Moderna CEO Stéphane Bancel was pleased with the cost efficiency achieved during the quarter ...

Moderna reported better third-quarter results than expected Thursday morning, as the vaccine maker reported a surprise profit ...

(NASDAQ:MRNA) today announced it was ranked the number one large employer in BioSpace's 2025 Best Places to Work report based on the Company's reputation and commitment to innovation. 'We are honored ...

Costochondritis — a benign condition that causes inflammation of the cartilage connecting your ribs to your breastbone. Also ...

Brad Miller, Moderna's CIO, has driven technology innovation to help drive continued gains for the roughly $7 billion revenue ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

Conversations focused on Innovative Whole Health Strategies: Where Care, Science, AI And Economics Converge Judy Faulkner, Stéphane Bancel and Annie Lamont to Speak at 2024 Summit ...

Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.

Harvard Street Neighborhood Health Center has received a $1.5 million commitment from Bancel Philanthropies that moves the organization closer to the construction of a new facility in Dorchester.

Moderna President Stephen Hoge, M.D., has taken on an expanded role, adding new responsibilities overseeing Moderna’s commercial organization. As President, Dr. Hoge will now be responsible for ...